LISA WILLIAMS: Open Payments
NPI 1407440878 · WESTAMPTON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,295 in 72 payments from 6 companies in 2025. Trend: 2023 $509 · 2024 $553 · 2025 $1,295
Food & beverage: $1,184Education: $111
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 27 | $405 |
| Neurocrine BioSciences, Inc. | 18 | $362 |
| E.R. Squibb & Sons, L.L.C. | 9 | $219 |
| Janssen Pharmaceuticals, Inc | 11 | $187 |
| Alkermes, Inc. | 5 | $88 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $35 |
Products named: INGREZZA, COBENFY, INVEGA SUSTENNA, UZEDY, AUSTEDO XR, ARISTADA, CAPLYTA.
Industry payments across NJ — which companies pay providers there.
